← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Cengent Therapeutics, Inc.
San Diego, CA
$2,447,735
Total funding
6
Grants
Funding mix
By agency
NIH$2,447,735 · 6
By mechanism
R44$2,148,750 · 3
R43$298,985 · 3
Investigators at Cengent Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
Non-Peptides Inhibitors of Anthrax Lethal Factor$383,032
R44 · FY2003 · AI
A SMALL MOLECULE DRUG SPECIFIC FOR HER2 INHIBITION$381,711
R44 · FY2002 · CA
A SMALL MOLECULE DRUG SPECIFIC FOR HER2 INHIBITION$372,652
R44 · FY2001 · CA
Non-Peptides Inhibitors of Anthrax Lethal Factor$371,227
R44 · FY2002 · AI
STRUCTURE BASED DESIGN OF NOVEL INTERLEUKIN-5 RECEPTOR$324,794
R44 · FY2002 · AI
STRUCTURE BASED DESIGN OF NOVEL INTERLEUKIN-5 RECEPTOR$315,334
R44 · FY2001 · AI
STRUCTURE-BASED DESIGN OF NOVEL BCL-2 ANTAGONISTS$100,000
R43 · FY2000 · CA
Design of Small Molecule Antagonists of EGF-EGFR Binding$99,688
R43 · FY2003 · CA
Structure-Based Design of Bacterial GTPase Inhibitors$99,297
R43 · FY2004 · AI